<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01884376</url>
  </required_header>
  <id_info>
    <org_study_id>10-009</org_study_id>
    <nct_id>NCT01884376</nct_id>
  </id_info>
  <brief_title>Clinical Study for the Treatment of Peripheral Nerve Defects With Neuromaix</brief_title>
  <acronym>PeRepair</acronym>
  <official_title>Klinische Interventionsstrategie Zur überbrückenden Behandlung Peripherer Nervendefekte Mit Neuromaix</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is the development and initial clinical application of the nerve guide&#xD;
      Neuromaix in humans to provide evidence for the safety and performance of the device.&#xD;
&#xD;
      Neuromaix is intended to be used as a guiding structure to bridge a peripheral nerve&#xD;
      discontinuity, and to create a conduit for axonal growth across the nerve gap.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Neuromaix nerve guide is an absorbable implant composed of porcine collagen, used to&#xD;
      bridge a peripheral nerve discontinuity, and to create a conduit for axonal growth across the&#xD;
      nerve gap. Neuromaix provides a protective environment for peripheral nerve regeneration&#xD;
      after injury. Neuromaix connects the proximal and distal ends of a transected nerve, allowing&#xD;
      regenerating axons to grow through the scaffold, into the distal nerve tissue towards the&#xD;
      target muscle or skin.&#xD;
&#xD;
      Neuromaix is composed of two parts. The Epimaix part provides the structural characteristics&#xD;
      needed to suture the nerve guide in place and to prevent ingrowth of scar tissue. The&#xD;
      Perimaix part provides a structure that mimics endoneurial tubes, providing guidance for the&#xD;
      regenerating axons while bridging the nerve gap.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proof of safety of the medical device Neuromaix</measure>
    <time_frame>12 months</time_frame>
    <description>The primary objective is the proof of safety of the medical device Neuromaix. key parameter: normal wound healing without complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effectiveness evaluation of the implant device Neuromaix</measure>
    <time_frame>12 months</time_frame>
    <description>The secondary objective is the evaluation of the effectiveness of the Neuromaix implantation (&quot;Performance arm of study&quot;).&#xD;
key parameters: axonal regeneration and recovery of sensory function</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Patients With a Scheduled (Diagnostic) Nervus Suralis Biopsy</condition>
  <arm_group>
    <arm_group_label>Neuromaix implantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of Neuromaix during an diagnostic nerve biopsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromaix</intervention_name>
    <arm_group_label>Neuromaix implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  both genders in the age between 18 und 70 years&#xD;
&#xD;
          -  patients who are scheduled for a nerve biopsy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  alcohol-related polyneuropathy&#xD;
&#xD;
          -  paraneoplastic polyneuropathy&#xD;
&#xD;
          -  present: immunosuppressive therapy&#xD;
&#xD;
          -  present: malignant tumor&#xD;
&#xD;
          -  peripheral vascular diseases&#xD;
&#xD;
          -  collagen diseases (e.g. existing keloid scars)&#xD;
&#xD;
          -  patients with an increased wound healing disorder (e.g. diabetics)&#xD;
&#xD;
          -  patients with chronic venous insufficiency (vein thrombosis, skin diseases)&#xD;
&#xD;
          -  patients with coagulation and bleeding disorders (ASA- or Marcumar-patients)&#xD;
&#xD;
          -  present: pregnancy&#xD;
&#xD;
          -  HIV, Hepatitis B or Hepatitis C infection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmet Bozkurt, PD Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Plastic Surgery, Hand Surgery and Burn Center,University Hospital RWTH Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Plastic Surgery, Hand Surgery and Burn Center, University Hospital RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>June 19, 2013</study_first_submitted>
  <study_first_submitted_qc>June 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2013</study_first_posted>
  <last_update_submitted>June 17, 2015</last_update_submitted>
  <last_update_submitted_qc>June 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>nerve biopsy</keyword>
  <keyword>nerve regeneration</keyword>
  <keyword>neuroma pain</keyword>
  <keyword>loss of sensation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

